Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)
Mandate

Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)

June 22, 2023 M&A

Vinge has advised EQT IX (”EQT”) in connection with the sale of shares in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 20 June 2023.

In total, 40 million shares were placed at a price of SEK 140 per share, corresponding to a total value of SEK 5.6 billion.
Vinge’s team consisted of Sofie Bjärtun and Linnéa Sellström.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025